Clinical trial
A Single-center Prospective Cohort Study to Explore the Efficacy and Prognosis of Dynamic Monitoring of Cerebrospinal Fluid ctDNA
NCT06315686 is registered in ClinicalTrials.gov with Jiangsu Province Nanjing Brain Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-center Prospective Cohort Study to Explore the Efficacy and Prognosis of Dynamic Monitoring of Cerebrospinal Fluid ctDNA
- Lead sponsor
- Jiangsu Province Nanjing Brain Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- September 29, 2022
- Completion date
- December 31, 2024
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nsclc